Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma

This study has been terminated.
(early stopping rule)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: June 13, 2011
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2017
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)